The medical oxygen market refers to the supply and distribution of oxygen for use in medical settings, such as hospitals, clinics, and home healthcare. Medical oxygen is used to treat patients with respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia, as well as those with other medical conditions that may cause hypoxemia or hypoxia (a deficiency in the amount of oxygen reaching the tissues of the body).

The global medical oxygen market has experienced significant growth in recent years, driven by factors such as the increasing prevalence of respiratory diseases, aging population, and rising healthcare expenditure. The COVID-19 pandemic has also contributed to the increased demand for medical oxygen, particularly in countries with high numbers of COVID-19 cases.

The market for medical oxygen is highly competitive, with a large number of players operating in the market. Some of the key players in the global medical oxygen market include Air Liquide, Linde plc, Praxair, Inc., Taiyo Nippon Sanso Corporation, and Air Products and Chemicals, Inc.